Cadaveric donor selection and management

Seminars in Respiratory and Critical Care Medicine

Volumn 27, Issue 5, 2006, Pages 492-500

  Studer, Sean M ^a   Orens, Jonathan B ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Extended criteria; Lung transplant; Organ donation; Organ procurement

Indexed keywords

CADAVER DONOR; DONOR SELECTION; GRAFT RECIPIENT; LUNG TRANSPLANTATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

CADAVER; DONOR SELECTION; HUMANS; LUNG TRANSPLANTATION;

EID: 33750547758     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-954607     Document Type: Review

References (62)

1. UNOS data. 2003. www.UNOS.org
2. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6(5 Pt 2):1212-1227
3. Bowdish ME, Barr ML. Living lobar lung transplantation. Respir Care Clin N Am 2004;10:563-579
4. Steen S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjoberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76:244-252
5. Olson L, Cravero L, Kisthard J, Ward S, Marks W. Donation after cardiac death has a minimal impact on thoracic organ recovery. Prog Transplant 2006;16:141-143
6. D'Alessandro AM, Fernandez LA, Chin LT, et al. Donation after cardiac death: the University of Wisconsin experience. Ann Transplant 2004;9:68-71
7. Cooper DK, Keogh AM, Brink J, et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 2000;19:1125-1165
8. Bart KJ, Macon EJ, Humphries AL Jr, et al. Increasing the supply of cadaveric kidneys for transplantation. Transplantation 1981;31:383-387
9. Evans RW. The actual and potential supply of organ donors in the United States. Clin Transpl 1990:329-341
10. Mackersie RC, Bronsther OL, Shackford SR. Organ procurement in patients with fatal head injuries: the fate of the potential donor. Ann Surg 1991;213:143-150
11. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA 1968;205:337-340
12. Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003;75:482-487
13. Rosendale JD, Kauffman HM, McBride MA, et al. Hormonal resuscitation yields more transplanted hearts with improved early function. Transplantation 2003;75:1336-1341
14. Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 2006;174:710-716
15. Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002;124:250-258
16. Kawut SM, Reyentovich A, Wilt JS, et al. Outcomes of extended donor lung recipients after lung transplantation. Transplantation 2005;79:310-316
17. Aigner C, Winkler G, Jaksch P, et al. Extended donor criteria for lung transplantation: a clinical reality. Eur J Cardiothorac Surg 2005;27:757-761
18. Lardinois D, Banysch M, Korom S, et al. Extended donor lungs: eleven years experience in a consecutive series. Eur J Cardiothorac Surg 2005;27:762-767
19. Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003;22:1183-1200
20. Miyoshi S, Trulock EP, Shaefers H, Hsie C, Patterson GA, Cooper JD. Cardiopulmonary exercise testing after single and double lung transplantation. Chest 1990;97:1130-1136
21. United Network for Organ Sharing. Guidelines for multi-organ donor management and procurement. UNOS Update 1993:14-15
22. Novick RJ, Bennett LE, Meyer DM, Hosenpud JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999;18:425-431
23. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time in intermediate survival and morbidity after lung transplantation. Chest 2000;118:1255-1262
24. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: eighteenth official report-2001. J Heart Lung Transplant 2001;20:805-815
25. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000;19:1199-1204
26. Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995; 109:T11075-1079
27. Sommers KE, Griffith BP, Hardesty RL, Keenan RJ. Early lung allograft function in twin recipients from the same donor: risk factor analysis. Ann Thorac Surg 1996;62:784-790
28. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: Fourteenth official report-1997. J Heart Lung Transplant 1997;16:691-694
29. Snell GI, Rabinov M, Griffits A, et al. Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation. J Heart Lung Transplant 1996;15:169-174
30. Gammie JS, Dtukus DR, Pham SM, et al. Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg 1999;68:2015-2020
31. Pierson RN III, Loyd JE, Goodwin A, et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 2002;74:79-84
32. Warren DS, Zachary AA, Sonnenday CJ, et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 2004;4:561-568
33. Starzl TE, Tzakis A, Makowka L, et al. The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc 1987;19:4492-4497
34. Yu NC, Haug MT III, Khan SU, et al. Does the donor-recipient ABO blood group compatibility status predict subsequent lung transplantation outcomes? J Heart Lung Transplant 1999;18:764-768
35. Novick RJ, Schafers HJ, Stitt L, et al. Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients. J Thorac Cardiovasc Surg 1995;110:1402-1413
36. Sato M, Gutierrez C, Kaneda H, Liu M, Waddell TK, Keshavjee S. The effect of gender combinations on outcome in human lung transplantation: the International Society of Heart and Lung Transplantation Registry experience. J Heart Lung Transplant 2006;5:634-637
37. Lillehei CW, Shamberger RC, Mayer JE, et al. Size disparity in pediatric lung transplantation. J Pediatr Surg 1994;29:1152-1155
38. Loring SH, Leith DE, Connolly MJ, Ingenito EP, Mentzer SJ, Reilly JJ. Model of functional restriction in chronic obstructive pulmonary disease, transplantation, and lung reduction surgery. Am J Respir Crit Care Med 1999;160:821-828
39. Otulana BA, Mist BA, Scott JP, Wallwork J, Higenbottam T. The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation 1989;48:625-629
40. Tamm M, Higenbottam T, Dennis CM, Sharples LD, Wallwork J. Donor and recipient predicted lung volume and lung size after heart-lung transplantation. Am J Respir Crit Care Med 1994;150:403-407
41. Lloyd KS, Barnard P, Holland VA, Noon GP, Lawrence EC. Pulmonary function after heart-lung transplantation using larger donor organs. Am Rev Respir Dis 1990;142:1026-1029
42. Wisser W, Klepetko W, Wekerle T, et al. Tailoring of the lung to overcome size disparities in lung transplantation. J Heart Lung Transplant 1996;15:239-242
43. Egan T, Thompson JT, Detterbeck FC, et al. Effect of size (mis) matching in clinical double-lung transplantation. Transplantation 1995;59:707-713
44. Ciccone AM, Stewart KC, Meyers BF, et al. Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg 2002;123:429-434
45. The US. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. The Organ Procurement and Transplant Network/SRTR Annual Report. 2005.
46. Torres A, el-Ebiary M, Rano A. Respiratory infectious complications in the intensive care unit. Clin Chest Med 1999;20:287-301
47. Ciulli F, Tamm M, Dennis CM, et al. Donor-transmitted bacterial infection in heart-lung transplantation. Transplant Proc 1993;25:1155-1156
48. Puskas JD, Winton TL, Miller JD, Scavuzzo M, Patterson GA. Unilateral donor lung dysfunction does not preclude successful contralateral single-lung transplantation. J Thorac Cardiovasc Surg 1992;103:1015-1017
49. Pierre AF, Sekine Y, Hutcheon M, Waddell TK, Keshavjee S. Marginal lung donors: a reassessment. J Thorac Cardiovasc Surg 2002;123:421-428
50. Harjula A, Baldwin JC, Starnes VA, et al. Proper donor selection for heart-lung transplantation. The Stanford experience. J Thorac Cardiovasc Surg 1987;94:874-880
51. Griffith BP, Zenati M. The pulmonary donor. Clin Chest Med 1990;11:217-226
52. Stewart S, Ciulli F, Wells FC, et al. Pathology of unused donor lungs. Transplant Proc 1993;25:1167-1168
53. Weill D, Dey GC, Young KR, et al. A positive donor Gram stain does not predict the development of pneumonia, oxygenation or duration of mechanical ventilation following lung transplantation [abstract]. J Heart Lung Transplant 2001;20:255
54. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999;160:265-271
55. Zenati M, Dowling RD, Dummer JS, et al. Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Lung Transplant 1990;9:502-509
56. Dowling RD, Zenati M, Yousem SA, et al. Donor-transmitted pneumonia in experimental lung allografts: successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg 1992;103:767-772
57. Bonde PN, Patel ND, Borja MC, et al. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant 2006;25:99-105
58. Avlonitis VS, Krause A, Luzzi L, et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003;24:601-607
59. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17:423-429
60. Conte JV Jr, Ferber LR, Borja M, et al. Lung transplantation from dialysis dependent donors. J Heart Lung Transplant 2000;19:894-896
61. Shumway SJ, Hertz MI, Petty MG, Bolman RM. Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg 1994;57:92-95
62. Penn I. Donor transmitted disease: cancer. Transplant Proc 1991;23:2629-2631